0001209191-20-008889.txt : 20200212
0001209191-20-008889.hdr.sgml : 20200212
20200212172224
ACCESSION NUMBER: 0001209191-20-008889
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20605570
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2020-02-10
4
F
0
12215
240.95
D
59268
D
Common Stock
2020-02-11
4
S
0
1000
243.53
D
58268
D
Common Stock
2020-02-11
4
S
0
3426
245.05
D
54842
D
Common Stock
2020-02-11
4
S
0
4320
245.99
D
50522
D
Common Stock
2020-02-11
4
S
0
1821
246.88
D
48701
D
Common Stock
2020-02-11
4
S
0
2103
247.98
D
46598
D
Common Stock
2020-02-11
4
S
0
400
248.73
D
46198
D
Common Stock
16190
I
Held in Trust
Common Stock
882
I
401(k)
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $243.53 (range $242.88 to $243.86).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $245.05 (range $244.50 to $245.47).
Open market sales reported on this line occurred at a weighted average price of $245.99 (range $245.50 to $246.45).
Open market sales reported on this line occurred at a weighted average price of $246.88 (range $246.53 to $247.39).
Open market sales reported on this line occurred at a weighted average price of $247.98 (range $247.55 to $248.50).
Open market sales reported on this line occurred at a weighted average price of $248.73 (range $248.60 to $248.82).
/s/ Omar White, Attorney-in-Fact
2020-02-12